NCT05297591View on ClinicalTrials.gov

Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Breast Cancer
Interventions
OTHER

assessment of UL function and prognostic factors

clinical assessments and questionnaires

Trial Locations (1)

3000

RECRUITING

Universitair Ziekenhuis Leuven, Leuven

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Vrije Universiteit Brussel

OTHER

lead

KU Leuven

OTHER

NCT05297591 - Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment | Biotech Hunter | Biotech Hunter